Price To Earnings Ratio 65.47 | Sector PE 70.55 |
PB Ratio 7.97 | Sector PB 8.91 |
EPS 12.69 | Dividend Yield 0.18 |
Today's Volume 612.235 K | 5 Day Avg. Volume 449.661 K |
PEG Ratio 6.78 | Market Cap. ₹ 33,860.00 Cr. |
Syngene International Limited is an integrated research, development and manufacturing service company operating in India. The company provides contract research and manufacturing services from lead generation to clinical supply to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) production, formulation and analytical development, and clinical development services. It offers SynVent, a therapeutic discovery and development platform for drug development projects. SynVent's portfolio spans categories and therapeutic areas from small molecule inhibitors to targeted protein stabilisation. It serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.